Group B Strep Surveillance and Trends

Key points

  • ÐÇ¿ÕÓéÀÖ¹ÙÍø conducts active surveillance for invasive group B Streptococcus (group B strep, GBS) disease.
  • Invasive disease refers to when bacteria invade parts of the body, like blood, that are normally free from germs.
  • GBS bacteria remain a leading cause of meningitis and bloodstream infections in newborns younger than 3 months old.
  • Learn how ÐÇ¿ÕÓéÀÖ¹ÙÍø tracks GBS disease in the United States.
Drawing of a germ and microscope, with graphs behind.

Data systems

GBS disease is not reportable in most states.

Active Bacterial Core surveillance

ÐÇ¿ÕÓéÀÖ¹ÙÍø conducts active surveillance for invasive GBS disease through Active Bacterial Core surveillance (ABCs). ABCs is part of ÐÇ¿ÕÓéÀÖ¹ÙÍø's Emerging Infections Program.

Keep Reading: Active Bacterial Core surveillance (ABCs)

Bact Facts Interactive

You can analyze and visualize ABCs GBS data.

Use Bact Facts Interactive

How the data are interpreted

GBS bacteria emerged in the 1970s as the most common cause of sepsis in newborns. More recently, experts recognized the increasing impact invasive GBS disease has on adults.

Disease burden

Tens of thousands invasive GBS disease cases occur annually in the United States in all age groups.

GBS bacteria remain a leading cause of meningitis and bloodstream infections in newborns younger than 3 months old.

Disease trends

As use of intrapartum antibiotic prophylaxis increased, GBS disease declined by 80% in babies younger than one week old:

  • Infection rate in 1993: 1.7 cases per 1,000 live births
  • Infection rate in 2023: 0.2 cases per 1,000 live births

Data reporting

View ABCs annual reports for GBS disease.

Print
Content Source:
National Center for Immunization and Respiratory Diseases; Division of Bacterial Diseases